Advanced Healthcare Materials · 2023 · 23 citations · 23 references
Life SciencesBiotechnologyOncologyBioorthogonal ChemistryMolecular OncologyNanobiotechnologyCancer NanomedicineImmunomagnetic SeparationMagnetic NanomaterialsMagnetic SeparationNanomedicineActive Tumor TargetingClick ChemistryEarly DiagnosisExtracellular VesiclesMagnetic LiposomesMagnetic NanoparticlesNanoparticlesPersonalized Cancer Treatment
Abstract The capture of melanoma circulating tumor cells (melanoma CTCs, MelCTCs) is of great significance for the early diagnosis and personalized treatment of melanoma. The rarity and heterogeneity of MelCTCs have greatly limited the development of MelCTCs capture methods, especially those based on immune/aptamer‐affinity. Herein, an extracellular vesicles‐camouflaged strategy is designed to functionalize the magnetic nanoparticles (Fe 3 O 4 ) and to generate magnetic vesicles (Fe 3 O 4 @lip/ev) with excellent antifouling and active tumor cell targeting properties. Combined with the bioorthogonal click chemistry, the engineered magnetic vesicles with dibenzocyclooctyne can be widely used to target and separate all the metabolically labeled CTCs with varied phenotypes, organ origin, and even the biological species. The capture efficiency exceeded 80% with an extremely low detection limitation of ten cells. Most importantly, the strategy proposed can be directly applied to enrich MelCTCs from 0.5 mL blood samples of melanoma‐bearing mice, with a greatly minimized residue of white blood cells (only 21–568) while ignoring the fluctuations of MelCTC phenotype.
23
Toward Minimal Residual Disease-Directed Therapy in Melanoma
Florian Rambow, Aljosja Rogiers, Oskar Marín-Béjar et al. · Cell · 2018 · 771 citations · Full text
Medicine, Dermatology, Oncology +12
Biomarker Utility of Circulating Tumor Cells in Metastatic Cutaneous Melanoma
Leila Khoja, Paul Lorigan, Cong Zhou et al. · Journal of Investigative Dermatology · 2012 · 137 citations · Full text
Medicine, Dermatology, Oncology +16